NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
18.38
-2.09 (-10.21%)
At close: Apr 1, 2025, 4:00 PM
18.78
+0.40 (2.18%)
After-hours: Apr 1, 2025, 5:29 PM EDT

NAMS Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
2,0182,751920889139-
Market Cap Growth
199.19%199.19%3.44%537.58%--
Enterprise Value
1,1852,329501796144-
Last Close Price
18.3825.7011.1710.909.75-
PS Ratio
38.0660.3865.268.66--
PB Ratio
2.623.633.192.072.46-
P/TBV Ratio
3.643.643.192.072.46-
P/FCF Ratio
--85.12--
P/OCF Ratio
--83.36--
EV/Sales Ratio
26.0051.1235.567.75--
EV/FCF Ratio
--76.18--
Debt / Equity Ratio
0.000.00000.00-3.26
Debt / FCF Ratio
---0.01--
Asset Turnover
0.080.080.030.38--
Quick Ratio
8.008.006.8613.035.810.61
Current Ratio
8.078.076.9513.265.960.72
Return on Equity (ROE)
-46.20%-46.20%-49.25%-9.30%-159.01%-
Return on Assets (ROA)
-18.19%-18.19%-27.70%-0.81%-55.71%-
Return on Capital (ROIC)
-21.06%-21.06%-31.82%-0.91%-66.25%-
Earnings Yield
-11.97%-8.78%-19.24%-2.55%-29.97%-
FCF Yield
-7.89%-5.79%-15.36%1.18%-21.18%-
Buyback Yield / Dilution
-14.84%-14.84%-333.20%-72.75%-119.58%-
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q